Funding
INFECTIOUS DISEASES, ALLERGY
This clinical trial was funded by Intrexon Actobiotics N.V. d/b/a Precigen ActoBio. The mechanistic assays and immunological data analysis were sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) under award no. UM1AI109565. This report is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.